US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
カナダ
TSX
Fennec Pharmaceuticals Inc (FRX)
Fennec Pharmaceuticals Inc (FRX) ニュース

FRX

Fennec Pharmaceuticals (FRX)

Fennec Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:FRX

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/18	16 : 00	PR Newswire (US)	Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	TSX:FRX	Fennec Pharmaceuticals Inc
2017/09/14	01 : 39	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
2017/09/14	01 : 35	PR Newswire (Canada)	IIROC Trade Resumption - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
2017/09/13	22 : 32	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
2017/09/13	22 : 29	PR Newswire (Canada)	IIROC Trading Halt - FRX	TSX:FRX	Fennec Pharmaceuticals Inc
2015/06/02	00 : 00	PR Newswire (US)	Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting	TSX:FRX	Fennec Pharmaceuticals Inc
2009/08/28	07 : 31	PR Newswire (US)	Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce	NYSE:FRX
2009/08/10	20 : 00	PR Newswire (US)	Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD	NYSE:FRX
2009/06/22	22 : 20	PR Newswire (US)	Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham	NYSE:FRX
2008/05/21	00 : 30	PR Newswire (US)	Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f	NYSE:FRX
2007/11/08	22 : 30	PR Newswire (US)	Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show	NYSE:FRX
2007/05/02	00 : 49	PR Newswire (US)	Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol	NYSE:FRX
2006/02/16	08 : 07	PR Newswire (US)	/C O R R E C T I O N -- Forest Laboratories, Inc./	NYSE:FRX

Showing the most relevant articles for your search:TSX:FRX

1

Magellan 5% until 8apr27

Invesco Global Buyback A...

BNP Paribas Issuance

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約